A multicenter prospective cohort study evaluating impact of an active delisting strategy to enable kidney transplantation in wait-listed candidates with calculated Panel Reactive Antibody ≥ 99.9%
Corrigendum to “Assessment of biological organ age using molecular pathology in pre-transplant kidney biopsies.� Kidney International 2024;106:302–316